1 / 22

Morning Report

Morning Report. Ralph Yachoui 12/8/09. The Case. CC: Skin Rash HPI: 46 y/o hispanic F p/w . 1 month h/o diffuse skin rash, first started on the arms, subsequently spreading to the upper chest, back and limbs. Pruritic and painful

libitha
Télécharger la présentation

Morning Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Morning Report Ralph Yachoui 12/8/09

  2. The Case • CC: Skin Rash • HPI: 46 y/o hispanic F p/w . 1 month h/o diffuse skin rash, first started on the arms, subsequently spreading to the upper chest, back and limbs. Pruritic and painful . Fever 100.4 on admission; 30lbs weight loss over 2 months

  3. The Case ( continued…) • PMH/PSH: Hypothyroidism • Medications: Levothyroxine • Allergies: NKDA • SH: Denies Etoh, drugs and smoking • FH: No significant family history

  4. Physical examination Fig 1: Numerous erythematous, annular and scaly plaques, some of them coalesced on the back.

  5. Fig 2: Multiple longitudinal bands of melanonychia Physical examination

  6. Physical examination • Per Derm: Rash looks like bullous erythema multiforme. Biopsies obtained • Per Rheum: Rash looks like Subacute cutaneous lupus erythematosus • Remaining of physical was unremarkable

  7. Labs • Hb : 8.5 MCV : 69 • WBC : 1.5 • Plt : 157 • Smear: teardrop cells c/w myelophthisic process

  8. Peripheral smear

  9. Labs . Iron 18 [42-135] Ferritin 360 [7- 160] Transferrin 140 [200-400] . Hb variants: Hb A 95% [ 96-100] Hb A2 6% [ 0- 3.5] Hb F 0 [ <2] Hb S undetected

  10. Labs .LFTs: Alk phos 64 T Bili 2.5 D Bili 0.1 AST 17 ALT 18 . Haptoglobin 23 [ 30- 200] LDH 420 [ 110- 230] . DAT ( Direct Coombs test) :positive IgG : positive

  11. Labs • PTT : 43.3 [ 22- 33] INR : 1 • Mixing studies: NO correction of PTT ! • LA panel : normal • Factor 2-10-9 : normal Factor 8 : 200% [ 60-189] Factor 12 ( Hageman) : 38% [50-150]

  12. Labs • HIV : neg • RPR : neg • Hepatitis panel : neg • Fungal and AFB bld cultures : neg • CRP 0.86 [< 0.5] ESR 68 [<48] • SPEP: Polyclonal hypergammaglobulinemia

  13. Imaging • CT C/A/P : . Right axillary LAD . Scattered ground glass parenchymal opacities bilaterally . Mild bilateral pleural effusion . Top normal spleen size

  14. Biopsy • A 4mm punch biopsy of skin lesion on the back showed perivascular lymphocytic infiltrate and widespread keratinocyte necrosis c/w bullous erythema multiforme

  15. Additional workup • C3 : 50 [ 86-184] • C4 : 27 [ 20-59] • C-ANCA/ P-ANCA : neg • Anti- myeloperoxidase : 10 [> 9 positive] • Anti-ribosomal P : neg • Anti- SCl 70: neg • Ro( SSA) / La (SSB) : neg • RF : neg

  16. Additional workup • Anti- cardiolipin : neg Anti- b2 glycoprotein IgA : 13 [<10] LA ( Hex phas, DRVVT) : neg • ANA : positive homogenous > 640 Speckled 0 Nucleolar 0

  17. Additional workup • ENA SM AB : 1.2 pos RNP AB : 1.2 pos • Anti- ds DNA : 1149 pos DIAGNOSIS: SLE with EM= Rowell syndrome

  18. Rowell syndrome • Original criteria for Rowell syndrome: 1- Lupus erythematosus 2- Erythema multiforme 3- Immunologic abnormalities in the serum: . Speckled pattern of antinuclear antibody (ANA) . Anti-La (SSB) antibody . Positive rheumatoid factor (RF)

  19. Rowell Syndrome (RS) • Since its first description in 1963 by Rowell et al , Rowell Syndrome has been reported in 37 patients, often not respecting the initial criteria…. • Some authors postulate that RS represent a subset of SCLE with targetoid lesions.

  20. Subacute cutaneous lupus erythematosus(SCLE) • First described by Sontheimer et al in 1979 as a distinct subset of cutaneous lupus characterized by: 1- Psoriasiform or annular lesions 2- Mild systemic involvement 3- Anti-Ro (SSA) antibodies 4- Associated with HLA-DR3

  21. SCLE ( psoriasiform lesions ) SCLE

  22. SCLE ( annular lesions) SCLE

More Related